Evidence map›Paper›PMID 41492611›Full record

ArticleCureus2025

Challenges in Managing Brain Metastases From Merkel Cell Carcinoma in an Immunosuppressed Patient: A Case Report.

Francisco Rebelo, Teresa Morais Pinheiro, João Pimentel, Carlos Pontinha, Julia Gerhardt

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Francisco RebeloNeurosurgery, Unidade Local de Saúde de São José, Lisbon, PRT.
Teresa Morais PinheiroNeurosurgery, Unidade Local de Saúde de São José, Lisbon, PRT.
João PimentelPathology, Unidade Local de Saúde de São José, Lisbon, PRT.
Carlos PontinhaPathology, Unidade Local de Saúde de São José, Lisbon, PRT.
Julia GerhardtNeurosurgery, Unidade Local de Saúde de São José, Lisbon, PRT.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Merkel cell carcinoma (MCC) is a rare but aggressive neuroendocrine tumor with high rates of metastasis and poor prognosis. While MCC commonly metastasizes to the lymphatic system, distant central nervous system (CNS) involvement is unusual, often complicating early detection and treatment. We describe the case of a 58-year-old male with multiple comorbidities who presented with progressive left-sided weakness and disorientation. Imaging revealed a right frontal lesion with mass effect, and further scans identified an iliac and inguinal lymphadenopathy without a primary skin lesion. The initial inguinal lymph node biopsy was inconclusive, prompting surgical resection of the brain lesion. Histopathology confirmed neuroendocrine carcinoma with CK20 dot-like positivity, consistent with MCC. Despite interdisciplinary management, the patient experienced multiple complications, including a respiratory infection and progressive systemic deterioration, ultimately succumbing to septicemia. MCC with CNS metastasis is a rare and highly lethal condition. This case underlines the importance of early recognition and aggressive multidisciplinary management for potential improvement in prognosis, despite limited therapeutic options.

Indexed as

brain parenchyma metastasesimmunosuppresionmerkel cell carcinoma (mcc)merkel cell polyomavirusneuro-oncology surgery

Identifiers

PMID41492611
PMCPMC12765529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.